China & United States — National Institutes of Health
14 shared events · Importance 4 · Last updated Aug 20, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Domestic
China: Rejected lab leak claims; its Wuhan lab is central to the origins debate, affecting its international reputation.
United States — National Institutes of Health: Cancelled the bat coronavirus grant; its grant management and oversight are questioned.
Aug 17, 2026 · 57 articles
Tech
China: High prevalence of low education as a risk factor; study highlights need for targeted prevention.
United States — National Institutes of Health: Provided grant funding, supporting high-impact global health research.
Jul 12, 2026 · 7 articles
Domestic
China: China is implicated in the lab-leak theory, which could affect bilateral relations and perceptions of its role in the pandemic.
United States — National Institutes of Health: NIH's funding of research in China is under scrutiny, potentially affecting its reputation and future funding debates.
Aug 06, 2026 · 38 articles
Accidents
China: China>>> is developing an mRNA vaccine that has shown promise against Uganda — Bundibugyo in mice and has pledged to send medical specialists to the Democratic Republic of the Congo>>> to assist with the outbreak.
United States — National Institutes of Health: The United States — National Institutes of Health supported a 2018 animal study that demonstrated the efficacy of the BDBV289-N antibody candidate against the Bundibugyo strain.
May 18, 2026 · 505 articles
Accidents
China: China is noted as the country where the vast majority of hantavirus cases occur annually, providing context on the global prevalence of the virus.
United States — National Institutes of Health: The United States — National Institutes of Health>>>'s decision to end funding for global infectious disease research networks has drawn criticism amid ongoing outbreaks.
May 07, 2026 · 368 articles
Business
China: Regulatory progress; BLA accepted and designated for priority review.
United States — National Institutes of Health: Parent agency of NIA, indirectly supporting research.
Aug 24, 2026 · 6 articles
Tech
China: Involved through Tsinghua University, minor role.
United States — National Institutes of Health: Funded the study, demonstrating its commitment to dementia research.
Aug 05, 2026 · 24 articles
Domestic
China: China is referenced regarding pandemic origins, but it is not directly involved in the contempt vote. Its role is background.
United States — National Institutes of Health: NIH is implicated in the gain-of-function research controversy and provided documents to the committee. The scrutiny could affect its funding and public trust.
Jul 26, 2026 · 353 articles
Business
China: China market had a stockpiling effect in Q2 2025; Leqembi included in Commercial Insurance Innovative Drug List in Dec 2025, supporting future sales.
United States — National Institutes of Health: Parent of United States — National Institute on Aging; no direct impact.
Jul 29, 2026 · 6 articles
Business
China: China is a country where Medicenna Therapeutics has pending patent applications, indicating its efforts to expand intellectual property protection globally.
United States — National Institutes of Health: The United States — National Institutes of Health is a co-owner of one of the newly issued US patents, indicating its collaboration with Medicenna Therapeutics on IL-4 Superkine fusion proteins.
Jun 11, 2026 · 6 articles
Business
United States — National Institutes of Health: The United States — National Institutes of Health funds the Alzheimer's Clinical Trial Consortium, which provides infrastructure for clinical trials, including those involving Lecanemab.
May 25, 2026 · 7 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how China and United States — National Institutes of Health interact across events, view sentiment trends, and discover connected entities.
Open Dashboard